Table 4 Multivariate survival analysis for epithelial- and immune infiltrate-localized CXC-chemokine expression
| Â | Recurrence-free survival | Overall survival | ||
|---|---|---|---|---|
| Â | Hazard ratio | 95% CI ( P) | Hazard ratio | 95% CI ( P) |
UICC stage | ||||
 Stage II | 1 | 1.92–4.62 | 1 | 1.60–3.92 |
 Stage III | 2.98 | (P<0.001) | 2.50 | (P<0.001) |
Inflammatory infiltrate CXCL8 | ||||
 Negative | 1 | 0.36–0.85 | 1 | 0.462–1.147 |
 Positive | 0.55 | (P=0.007) | 0.728 | (P=0.171) |
